Nabriva Therapeutics plc Operating Cash Flow
Nabriva Therapeutics plc reported Operating Cash Flow of -$5.11 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-10-19
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was $511.00K.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$5.62M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$1.63M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$6.18M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for fiscal 2022 was -$36.71M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for fiscal 2021 was -$59.56M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for fiscal 2020 was -$71.33M.
- Nabriva Therapeutics plc net cash provided by (used in) operating activities for fiscal 2019 was -$71.89M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-19 | -$5.11M 10-Q · filed 2023-10-19 | -$6.73M derived: sum of 3 quarters · filed 2023-10-19 | -$12.91M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2023-03-31 | -$5.62M 10-Q · filed 2023-05-22 | -$7.24M derived: sum of 2 quarters · filed 2023-05-22 | -$13.42M derived: sum of 3 quarters · filed 2023-05-22 | -$26.46M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-12-31 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$7.80M derived: sum of 2 quarters · filed 2023-04-17 | -$20.84M derived: sum of 3 quarters · filed 2023-10-19 | -$36.71M 10-K · filed 2023-04-17 | |
| 2022-09-30 | -$6.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$19.22M derived: sum of 2 quarters · filed 2023-10-19 | -$35.09M 10-Q · filed 2022-11-10 | -$41.20M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-06-30 | -$13.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-19 | -$28.91M 10-Q · filed 2023-10-19 | -$35.03M derived: sum of 3 quarters · filed 2023-10-19 | -$48.27M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-03-31 | -$15.87M 10-Q · filed 2023-05-22 | -$21.99M derived: sum of 2 quarters · filed 2023-05-22 | -$35.23M derived: sum of 3 quarters · filed 2023-05-22 | -$53.80M derived: sum of 4 quarters · filed 2023-05-22 | |
| 2021-12-31 | -$6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$19.36M derived: sum of 2 quarters · filed 2023-04-17 | -$37.93M derived: sum of 3 quarters · filed 2023-04-17 | -$59.56M 10-K · filed 2023-04-17 | |
| 2021-09-30 | -$13.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$31.81M derived: sum of 2 quarters · filed 2022-11-10 | -$53.44M 10-Q · filed 2022-11-10 | -$66.80M derived: sum of 4 quarters · filed 2023-04-17 | |
| 2021-06-30 | -$18.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$40.20M 10-Q · filed 2022-08-03 | -$53.56M derived: sum of 3 quarters · filed 2023-04-17 | -$66.16M derived: sum of 4 quarters · filed 2023-04-17 | |
| 2021-03-31 | -$21.63M 10-Q · filed 2022-05-05 | -$34.99M derived: sum of 2 quarters · filed 2023-04-17 | -$47.59M derived: sum of 3 quarters · filed 2023-04-17 | -$64.85M derived: sum of 4 quarters · filed 2023-04-17 | |
| 2020-12-31 | -$13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$25.96M derived: sum of 2 quarters · filed 2023-04-17 | -$43.22M derived: sum of 3 quarters · filed 2023-04-17 | -$71.33M 10-K · filed 2023-04-17 | |
| 2020-09-30 | -$12.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$29.86M derived: sum of 2 quarters · filed 2021-11-09 | -$57.97M 10-Q · filed 2021-11-09 | -$73.45M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2020-06-30 | -$17.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$45.37M 10-Q · filed 2021-08-05 | -$60.86M derived: sum of 3 quarters · filed 2022-03-29 | -$75.59M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2020-03-31 | -$28.11M 10-Q · filed 2021-05-06 | -$43.59M derived: sum of 2 quarters · filed 2022-03-29 | -$58.33M derived: sum of 3 quarters · filed 2022-03-29 | -$79.38M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2019-12-31 | -$15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$30.22M derived: sum of 2 quarters · filed 2022-03-29 | -$51.27M derived: sum of 3 quarters · filed 2022-03-29 | -$71.89M 10-K · filed 2022-03-29 | |
| 2019-09-30 | -$14.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$35.78M derived: sum of 2 quarters · filed 2020-11-05 | -$56.41M 10-Q · filed 2020-11-05 | -$78.64M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | -$21.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$41.67M 10-Q · filed 2020-08-06 | -$41.75M 10-Q · filed 2019-08-08 | -$63.90M derived: sum of 3 quarters · filed 2021-03-11 | -$81.03M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$20.63M 10-Q · filed 2020-05-11 | -$42.86M derived: sum of 2 quarters · filed 2021-03-11 | -$59.99M derived: sum of 3 quarters · filed 2021-03-11 | -$77.01M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | -$22.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$39.36M derived: sum of 2 quarters · filed 2021-03-11 | -$56.38M derived: sum of 3 quarters · filed 2021-03-11 | -$72.72M 10-K · filed 2021-03-11 | |
| 2018-09-30 | -$17.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$34.15M derived: sum of 2 quarters · filed 2019-11-12 | -$50.49M 10-Q · filed 2019-11-12 | -$74.57M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | -$17.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$33.36M 10-Q · filed 2019-08-08 | -$57.44M derived: sum of 3 quarters · filed 2020-03-12 | -$72.49M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | -$16.34M 10-Q · filed 2019-05-10 | -$40.42M derived: sum of 2 quarters · filed 2020-03-12 | -$55.47M derived: sum of 3 quarters · filed 2020-03-12 | -$71.00M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | -$24.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$39.13M derived: sum of 2 quarters · filed 2020-03-12 | -$54.66M derived: sum of 3 quarters · filed 2020-03-12 | -$69.35M 10-K · filed 2020-03-12 | |
| 2017-09-30 | -$15.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$30.58M derived: sum of 2 quarters · filed 2018-11-06 | -$45.27M 10-Q · filed 2018-11-06 | -$55.87M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | -$15.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$30.22M 10-Q · filed 2018-08-09 | -$40.82M derived: sum of 3 quarters · filed 2019-03-12 | -$53.41M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | -$14.68M 10-Q · filed 2018-05-08 | -$25.29M derived: sum of 2 quarters · filed 2019-03-12 | -$37.88M derived: sum of 3 quarters · filed 2019-03-12 | ||
| 2016-12-31 | -$10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$23.20M derived: sum of 2 quarters · filed 2019-03-12 | -$48.33M 10-K · filed 2019-03-12 | ||
| 2016-09-30 | -$12.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$37.72M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$25.13M 10-Q · filed 2017-08-07 | ||||
| 2015-12-31 | -$21.86M 10-K · filed 2018-03-16 |